Objectives: Clinical guidelines act as a means of assisting clinicians in improving the quality of healthcare provided. We aim to assess the quality of currently available international orthodontic guidelines. Materials and methods: A cross-sectional systematic assessment of orthodontic clinical guidelines was undertaken. A Medline search using the keywords 'guideline', 'orthodontics', and 'dent', and search of specific dental and orthodontic organization websites for orthodontic-related clinical guidelines. Relevant guidelines published between 1999 and 2012 in English were identified. Draft guidelines and endorsements were excluded. The quality of each guideline was evaluated by a single calibrated assessor using the AGREE II instrument. Variation in the quality of guidelines produced by different organizations was also assessed. Results: Seventeen guidelines were included in this study. Overall, the reporting of scope and purpose (84.31, 95% CI: 70.91-97.72) and clarity of presentation (75.49,3) domains of the AGREE II instrument were deemed of high quality. Lower scores were obtained for the following domains: rigour of development (52.08, 95% CI: 37.59-66.57), editorial independence (47.06, stakeholder agreement (46.41, and applicability (27.45,. There was a noted difference in the individual domain scores of orthodontic guidelines produced by the different organizations. Conclusions: In relation to the AGREE II instrument, the quality of orthodontic guidelines for use in clinical practice are deemed sub-optimal. Variation in the quality of guidelines produced different organizations is evident.
Introduction
It is widely recognized that clinical decisions should be supported by the best available evidence and made in the best interests of the patient (1) . Clinical practice guidelines are 'systematically developed statements to assist practitioner and patient decisions about appropriate healthcare for specific clinical circumstances' (2) . The potential benefits of clinical guidelines include improving clinical outcomes, aid patient decision-making processes, improve cost-effectiveness by standardizing care, promote the use of evidence-based interventions, facilitate development of patient care pathways and provide gold standards for the assessment of current clinical practice. Guidelines may also ensure that outdated methods and/or practices are discontinued, highlight current deficiencies in clinical practice, and identify areas of research that are required and support funding applications (3) . Despite these reported benefits, there is also the potential for harm. Guidelines may European Journal of Orthodontics, 2017, 654-659 doi:10.1093/ejo/cjx017 Advance Access publication 5 April 2017 be incorrectly formulated and propose inappropriate recommendations based on poor evidence or anecdote, or not be applicable to a particular population or patient (3, 4) . Patient care may not be the central focus of the guideline development process, with costs and vested interests of clinicians and others taking precedence. Strict adherence to guidelines may reduce individualized patient-centred care. Lay versions of guidelines may confuse patients and affect the doctor-patient relationship. In addition, the ability of guidelines to influence interventions and public policy may be misused by special interest groups, leading to the inappropriate allocation of resources (3) . The fear that guidelines can reduce professional autonomy is also a considerable barrier to their widespread implementation (5) . It is essential that clinicians are able to evaluate the relevance of a guideline as it is the responsibility of the clinician to interpret the application of guidelines, regardless of the strength of evidence presented (6) . In the USA, clinical guidelines influencing clinical judgement is not deemed an acceptable defence in a court of law (7) . Guidelines should assist decision-making and not be used to replace clinical judgement.
With the expansion of national clinical guideline programmes and increasing publication of guidelines in the medical literature, governmental and professional bodies are encouraged to ensure that guidelines are of the highest quality before endorsing them (8) . The increased production of guidelines has been a source of concern due to variations in both quality and standards (9) (10) (11) . A 10-year review of the quality of guidelines produced by specialty societies identified that the majority did not report how the evidence was identified (10) . In addition, the greatest areas of improvement required were identification, evaluation, and synthesis of scientific evidence (11) . The AGREE instrument (Appraisal of Guidelines, Research, and Evaluation) first developed in 2003 (8) and later revised and replaced by the AGREE II instrument, is a validated 23-item generic instrument divided into six domains designed to assess the development process and reporting of clinical guidelines (12) . Previous assessments of dental speciality guidelines have reported sub-optimal reporting of certain domains of the AGREE II instrument and very few were recommended for clinical practice use (13) (14) (15) . An assessment of the quality of orthodontic clinical guidelines has not been previously undertaken. The aim of this study was to conduct an exploratory evaluation of the reporting quality of orthodontic guidelines in relation to the AGREE II instrument.
Materials and methods

Guideline identification
A literature search was undertaken to identify orthodontic guidelines published between 1990 and 2012. Guidelines that were evaluated in the study had to be relevant to the speciality of orthodontics. The search was restricted to guidelines published in English and both draft guidelines and endorsements were excluded. The websites of international orthodontic organizations and other national dental organizations were searched for available orthodontic guidelines. A Medline search was carried out using the keywords 'guideline', 'orthodontics', and 'dent'. Searches using these terms were also undertaken on the websites of the World Health Organization (WHO), World Dental Federation (FDI) website, health departments of English-speaking countries, national guideline development groups in England, Scotland, USA, New Zealand, Australia, and Canada and using the Google © search engine. A single investigator (TT) screened all potentially relevant guidelines independently and any discrepancies were resolved by discussion with a second investigator (MTC) to reach a consensus.
AGREE II Instrument
The AGREE II instrument (12) consists of 23 key items categorized into 6 domains, each measuring a different aspect of guideline quality ( Table 1) . Each of the AGREE II items are rated on a seven-point Likert scale ranging from 7 'Strongly Agree' (quality of reporting is exceptional and where the full criteria and considerations have been met) to 1 'Strongly Disagree (no information that is relevant to the AGREE II item or if the concept is very poorly reported). A score was assigned based upon the reporting of the item in relation to the full criteria or considerations, its level of completeness, and quality of reporting. An overall assessment was also undertaken which rates the overall quality of the guideline and whether the guideline would be recommended for use in practice. In accordance with previous studies (13) , guidelines were rated as: strongly recommend, recommend with provisos, and not recommend. In general, the higher the score, the better the quality of the guideline as assessed by the instrument. All questions on the domains are given equal weighting. Variation in the quality of guidelines produced by different organizations was also assessed.
Evaluation of the guidelines
A single independent assessor (TT) evaluated the guidelines independently. This assessor was calibrated in the use of the AGREE II instrument, having completed the online training tool (www. agreetrust.org). Each guideline was assessed by referring directly to the AGREE II instrument and referring directly to the associated explanation of each item as stated in the user manual.
Statistical analysis
Descriptive statistics were utilized. Domain scores were calculated by summing up all the scores of the individual items in a domain and by scaling the total as a percentage of the maximum possible score for that domain. The mean overall scores (95% confidence interval, CI) for each domain were calculated.
Results
A total of 17 guidelines from 8 different organizations were identified ( Table 2 ). The mean overall score (95% CI) for each domain of the AGREE II Tool instrument is presented in Analysis of the average domain scores of orthodontic guidelines produced by the different organizations is described. In domain 1 (Scope and purpose) all the guideline developing organizations with the exception of the Royal College of Surgeons of England (RCS) (40.3%) scored 100%. The RCS guidelines did specifically describe the overall objectives of the guideline well. However, neither the specific health questions nor the population to whom the guideline is meant to apply were clearly described. In domain 2 (Stakeholder involvement), only the American Association of Orthodontists (AAO) guideline scored 100% in this category followed by Scottish Intercollegiate Guidelines Network (SIGN) guidelines (94.4%). National Institute for Health and Care Excellence (NICE), International Association for Dental Traumatology (IADT) and SedentexCT scored above 50% in this domain, with British Orthodontic Society (BOS) (38.9%), American Association of Paediatric Dentistry (AAPD) (33.3%), and RCS (12.2%) achieving low scores. The guidelines that scored poorly in this domain did identify target users but failed to included relevant professionals from all groups. The majority of guidelines failed to obtain the views and preferences of the target population (patients, public). In domain 3 (Rigour of Development), SIGN guidelines achieved the highest sore (100%), followed by NICE (91.7%), and SedentexCT (87.5%). The remainder of the five organizations scored below The overall objective(s) of the guideline is (are) specifically described 2. The health question(s) covered by the guideline is (are) specifically described 3. The population (patients, public, etc.) to whom the guideline is meant to apply is specifically described Domain 2
Stakeholder involvement 4. The guideline development group includes individuals from all the relevant professional groups 5. The views and preferences of the target population (patients, public, etc.) have been sought 6. The target users of the guideline are clearly defined Domain 3
Rigour of development 7. Systematic methods were used to search for evidence 8. The criteria for selecting the evidence are clearly described 9. The strengths and limitations of the body of evidence are clearly described 10. The methods for formulating the recommendations are clearly described 11. The health benefits, side effects, and risks have been considered in formulating the recommendations 12. There is an explicit link between the recommendations and the supporting evidence 13. The guideline has been externally reviewed by experts prior to its publication 14. A procedure for updating the guideline is provided 50% with the lowest score obtained by IADT (28.1%). Overall for domain 4 (Clarity of presentation), all guideline development organizations with the exception of AAPD (27.8%) scored above 50% in this domain, with SIGN, BOS, and SedentexCT scoring 100% and NICE scoring 94.4%. In domain 5 (Applicability), the highest score was achieved by SedentexCT guideline (100%) followed by NICE (76.4%) and SIGN (75%). Lower scores were achieved by RCS (9.2%), BOS (12.5%), and AAO (4.2%). Both AAPD and IADT scored 0%. In this domain, facilitators and barriers to guideline application, tools/advice and potential resource implications had not been considered. Moreover, the guidelines did not present monitoring and/or auditing criteria once the guidelines had been implemented. In domain 6 (Editorial Independence), SIGN, NICE, and SedentexCT scored 100% as did the AAPD. The remainder of the guideline developing organizations scored 0%. In this domain, guidelines did not clearly state whether the views of the funding body influenced the guideline content and whether any competing interests of the guideline development group members were recorded and addressed. Regarding overall assessment and quality, guidelines produced by SIGN, NICE, and SedentexCT can be recommended for use in practice. AAO guidelines can be recommended with proviso. The RCS, BOS, AAPD, and IADT guidelines cannot be recommended based on their overall compliance with the AGREE II instrument.
Discussion
The AGREE II instrument is a reliable and valid tool that can be used to the assess the quality of current orthodontic guidelines. Furthermore, this instrument has been endorsed by the World Health Organization (WHO) and is considered as the standard in guideline assessment (16) . The primary aim of this study was to assess the reporting quality of orthodontic guidelines in relation to the AGREE II instrument. Overall, the quality was deemed sub-optimal with deficiencies relating to rigour of development, editorial independence, stakeholder agreement and applicability recorded. Similar findings have been previously reported in the assessment of dental and medical guidelines. In the assessment of dental guidelines using the original AGREE instrument the reporting of Scope and Purpose scored highly with a mean score 91% (15) and with a median score of 67% (13) . However, the remaining domains generally scored poorly with average domains scores not exceeding 36% (13) . Within the medical speciality, a comprehensive assessment of 626 guidelines in relation to the AGREE instrument found acceptable scores for Scope and Purpose (64%) and Clarity and Presentation (60%), moderate scores for 'Rigour of Development' (43%) and low scores for 'Stakeholder Involvement' (35%), 'Editorial Independence' (30%), and 'Applicability' (22%) (17) . The majority of guidelines in this study attempted to demonstrate an explicit link between the recommendations, the supporting evidence, considered health benefits, side effects, and risks in formulating the recommendations. However, reasons for low scores included: guidelines were not specific and ambiguous, different options for managing the condition were not clearly presented and key recommendations were not easily identifiable. Summary documents, quick reference guides presented in relevant sections possibly as algorithms or flowcharts were not frequently used. There was also a lack of demonstration of both a systematic method was employed to search for the evidence and a description of the criteria for selecting evidence along with the strengths and limitations of the body of evidence. In addition, guidelines did not report the methods used to formulate the recommendations or that the guidelines have been reviewed externally by experts prior to its publication. Often procedures for updating the guideline were not described despite many of the guidelines being updated periodically.
Overall, it appears that the principal reason for the poor quality of orthodontic guidelines is the lack of reporting of the guideline development process. AGREE II concentrates on the guideline development process and the reporting. These aspects of guideline development are very important despite the apparent lack of correlation between methodological rigour and validity (18) . Another poorly performing domain was 'Applicability', where the facilitators and potential barriers, cost implications to guideline implementations were not considered. The clinical relevance of this may result in guidelines recommending costly interventions or those that are not feasible to apply in certain healthcare settings. Furthermore, once guidelines have been implemented, the guidelines did not have any monitoring or auditing criteria to ensure appropriate implementation.
The secondary aim was to assess the variation in the quality of guidelines produced by different organizations. Evaluation of orthodontic guidelines by the AGREE II tool has highlighted that guidelines produced by organizations other than NICE, SIGN, and SedentexCT had low scores in almost all domains with the exception of scope and purpose and clarity of presentation. These finding are not dissimilar to other studies (19) . The NICE and SIGN guidelines appear to confirm a stringent and clear methodology in their development process which complies with the AGREE instrument. The SedentexCT guideline was developed following the methods outlined by the Scottish Intercollegiate Guideline Network (20) . Unsurprisingly, when guidelines produced by these organizations are evaluated by the AGREE II instrument, they score highly. Organizations such as RCS and IADT performed poorly using the AGREE II tool due to lack of reporting of the guideline development process. The RCS does have a Clinical Standards Committee whose goal is 'nationwide improvement in clinical outcomes in all dental specialties.' It briefly outlines its role, its members and the meeting dates and directs access to all the published guidelines. However, there is no other supporting documentation. The IADT does not give any indication of guideline development process on its website. To reduce disparities in the quality of guidelines produced by different organizations, a standardized approach guideline development has been recommended (21, 22) . The National Guideline Clearing House is an example of how guideline production is standardized, emphasizing good methodology by having inclusion criteria and content methodology before guidelines are included in their database (23). Use of the appropriate tools to ensure a reliable, reproducible selection and appraisal of evidence during the systematic review of stage for guideline development is essential (21, 22, 24) .
Overall, seventeen online orthodontic English language guidelines were identified. A search using 'orthodontics' revealed no results while using 'orthodontic' resulted in only one guideline by NICE on mini/micro screw implants for orthodontic anchorage being identified. In contrast the term 'dent' resulted in thirteen guidelines however only one was relevant to orthodontics. The difficulty in identifying guidelines has been previously reported, however to overcome this adopting a range of search strategies has been advocated (14, 19) . Globally, English is one of the most commonly spoken languages. It is not surprising that most clinical guidelines appear to be published in English (25) . Potentially relevant non-English orthodontic guidelines could have been excluded from this study. However, the inclusion of non-English guidelines may have compromised the validity of the findings if discrepancies within the translated text occurred. Generally, the identification of guidelines to be included in this study was hindered by both access and location. The use and implementation of guidelines is dependent on their accessibility. The National Health Service national library of guidelines (26) is accessible in the public domain and incorporates international guidelines from the US National Guidelines Clearing House, New Zealand Guidelines Group-Guidelines Library and Australian National Health and Medical Research Council: Clinical Practice Guidelines. The Guidelines International Network (G-I-N) provides access to a library of over 6700 guidelines. Accessibility to guidelines in the public domain could facilitate international collaboration and therefore advancement in guideline development. However, barriers such as restriction to fee-paying members only and institutional log-ins may preclude widespread dissemination and usage of clinical guidelines.
The AGREE II instrument does not assess content validity of guidelines (18) or quality of the evidence but is designed to improve the reporting of methodology, to ensure it is transparent, clear and any conflicts of interest have been taken into account. A high score on the AGREE II instrument indicates that the information meets these criteria. However, a high quality methodology does not suggest that poor quality of evidence has not been used. In theory, therefore, a guideline could be produced with poorly supported recommendations despite a vigorous guideline development method (27) . An unsystematic guideline development process infers that important steps in the guideline development process have not have been included. This may result in a guideline of poor quality which could ultimately compromise patient care by suggesting ineffective or harmful treatment. Several reasons could lead to this including lack of robust evidence, 'expert opinions' which are biased as result of personal experience, imbalance among relevant professionals in the guideline development group and unaccounted patient's needs (3) . Regardless of the hierarchy of evidence from which recommendations are based, the AGREE instrument suggests that there should be an explicit link between the recommendations and the evidence upon which they are based.
The AGREE II tool has been utilized and tested for its validity, reliability and applicability in various geographical and healthcare specialty guideline development processes (8, 12, 28) . However, there are no threshold scores described in the AGREE II for determining the overall quality of a guideline. This leaves guideline assessors open to interpret scores and therefore the scores of an AGREE II evaluation have to be interpreted with caution and in the appropriate context in which they are used (29) . In the current study, one independent assessor evaluated the guidelines. The AGREE Collaboration recommends two assessors but preferably at least four should be used during guideline appraisal (12) . This recommendation is based on the perceived improvement in inter-rater level of agreement. Importantly, the level of clinical experience of the assessor does not appear to impact the scores in the different AGREE domains (28) . Despite this, reliability for some domains only reaches a moderate level of agreement (0.63) even when multiple assessors are utilized (30) . The recommended use of four assessors is not consistently followed throughout the literature, and 2-3 individuals are often used to appraise guidelines using the AGREE instrument (14, 17, 19) . The use of a single assessor in a study of this nature has also been previously employed (15) .
Conclusions
Overall, orthodontic guidelines were of poor quality as assessed by the AGREE II instrument. The guidelines produced by NICE, SIGN, and SedenctexCT, which utilized principles described by AGREE in their guideline development process, scored highly and can be recommended for use. The AGREE II instrument should be considered in the development of new guidelines and during the revision of old guidelines to improve their overall quality and validity.
